Global U.S. Contract Research Organization (CROs) Market Overview:
Global U.S. Contract Research Organization (CROs) Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global U.S. Contract Research Organization (CROs) Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of U.S. Contract Research Organization (CROs) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the U.S. Contract Research Organization (CROs) Market:
The U.S. Contract Research Organization (CROs) Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for U.S. Contract Research Organization (CROs) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study U.S. Contract Research Organization (CROs) Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, U.S. Contract Research Organization (CROs) market has been segmented into:
CROs
By Application, U.S. Contract Research Organization (CROs) market has been segmented into:
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb – IV
Medical coding and writing
Monitoring
Clinical Data Management
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The U.S. Contract Research Organization (CROs) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the U.S. Contract Research Organization (CROs) market.
Top Key Players Covered in U.S. Contract Research Organization (CROs) market are:
IQVIA INC.
ICON plc
Labcorp
Syneos Health
PROMETRIKA
LLC.
Premier Research
Caidya
Charles River Laboratories
Inc.
Parexel International Corporation
Medpace
Inc.
WuXi AppTec
Courante Oncology
EPS Corporation
Worldwide Clinical Trials
Tigermed
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: U.S. Contract Research Organization (CROs) Market by Type
4.1 U.S. Contract Research Organization (CROs) Market Snapshot and Growth Engine
4.2 U.S. Contract Research Organization (CROs) Market Overview
4.3 CROs
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 CROs: Geographic Segmentation Analysis
Chapter 5: U.S. Contract Research Organization (CROs) Market by Application
5.1 U.S. Contract Research Organization (CROs) Market Snapshot and Growth Engine
5.2 U.S. Contract Research Organization (CROs) Market Overview
5.3 Drug Discovery
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Drug Discovery: Geographic Segmentation Analysis
5.4 Preclinical studies
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Preclinical studies: Geographic Segmentation Analysis
5.5 Early Phase I - IIa
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Early Phase I - IIa: Geographic Segmentation Analysis
5.6 Phase IIa - III
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Phase IIa - III: Geographic Segmentation Analysis
5.7 Phase IIIb – IV
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Phase IIIb – IV: Geographic Segmentation Analysis
5.8 Medical coding and writing
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Medical coding and writing: Geographic Segmentation Analysis
5.9 Monitoring
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Monitoring: Geographic Segmentation Analysis
5.10 Clinical Data Management
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Clinical Data Management: Geographic Segmentation Analysis
5.11 and Others
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 U.S. Contract Research Organization (CROs) Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 IQVIA INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ICON PLC
6.4 LABCORP
6.5 SYNEOS HEALTH
6.6 PROMETRIKA
6.7 LLC.
6.8 PREMIER RESEARCH
6.9 CAIDYA
6.10 CHARLES RIVER LABORATORIES
6.11 INC.
6.12 PAREXEL INTERNATIONAL CORPORATION
6.13 MEDPACE
6.14 INC.
6.15 WUXI APPTEC
6.16 COURANTE ONCOLOGY
6.17 EPS CORPORATION
6.18 WORLDWIDE CLINICAL TRIALS
6.19 AND TIGERMED
Chapter 7: Global U.S. Contract Research Organization (CROs) Market By Region
7.1 Overview
7.2. North America U.S. Contract Research Organization (CROs) Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 CROs
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Drug Discovery
7.2.5.2 Preclinical studies
7.2.5.3 Early Phase I - IIa
7.2.5.4 Phase IIa - III
7.2.5.5 Phase IIIb – IV
7.2.5.6 Medical coding and writing
7.2.5.7 Monitoring
7.2.5.8 Clinical Data Management
7.2.5.9 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe U.S. Contract Research Organization (CROs) Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 CROs
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Drug Discovery
7.3.5.2 Preclinical studies
7.3.5.3 Early Phase I - IIa
7.3.5.4 Phase IIa - III
7.3.5.5 Phase IIIb – IV
7.3.5.6 Medical coding and writing
7.3.5.7 Monitoring
7.3.5.8 Clinical Data Management
7.3.5.9 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe U.S. Contract Research Organization (CROs) Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 CROs
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Drug Discovery
7.4.5.2 Preclinical studies
7.4.5.3 Early Phase I - IIa
7.4.5.4 Phase IIa - III
7.4.5.5 Phase IIIb – IV
7.4.5.6 Medical coding and writing
7.4.5.7 Monitoring
7.4.5.8 Clinical Data Management
7.4.5.9 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific U.S. Contract Research Organization (CROs) Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 CROs
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Drug Discovery
7.5.5.2 Preclinical studies
7.5.5.3 Early Phase I - IIa
7.5.5.4 Phase IIa - III
7.5.5.5 Phase IIIb – IV
7.5.5.6 Medical coding and writing
7.5.5.7 Monitoring
7.5.5.8 Clinical Data Management
7.5.5.9 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa U.S. Contract Research Organization (CROs) Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 CROs
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Drug Discovery
7.6.5.2 Preclinical studies
7.6.5.3 Early Phase I - IIa
7.6.5.4 Phase IIa - III
7.6.5.5 Phase IIIb – IV
7.6.5.6 Medical coding and writing
7.6.5.7 Monitoring
7.6.5.8 Clinical Data Management
7.6.5.9 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America U.S. Contract Research Organization (CROs) Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 CROs
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Drug Discovery
7.7.5.2 Preclinical studies
7.7.5.3 Early Phase I - IIa
7.7.5.4 Phase IIa - III
7.7.5.5 Phase IIIb – IV
7.7.5.6 Medical coding and writing
7.7.5.7 Monitoring
7.7.5.8 Clinical Data Management
7.7.5.9 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
U.S. Contract Research Organization (CROs) Scope:
|
Report Data
|
U.S. Contract Research Organization (CROs) Market
|
|
U.S. Contract Research Organization (CROs) Market Size in 2025
|
USD XX million
|
|
U.S. Contract Research Organization (CROs) CAGR 2025 - 2032
|
XX%
|
|
U.S. Contract Research Organization (CROs) Base Year
|
2024
|
|
U.S. Contract Research Organization (CROs) Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
IQVIA INC., ICON plc, Labcorp, Syneos Health, PROMETRIKA, LLC. , Premier Research, Caidya, Charles River Laboratories, Inc., Parexel International Corporation, Medpace, Inc., WuXi AppTec, Courante Oncology, EPS Corporation, Worldwide Clinical Trials, and Tigermed.
|
|
Key Segments
|
By Type
CROs
By Applications
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb – IV
Medical coding and writing
Monitoring
Clinical Data Management
and Others
|
